Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination therapy approach that utilizes both Hirudinaria granulosa (medicinal leech) and Qurs Mafasil (a Unani polyherbal formulation). Hirudinaria granulosa is a buffalo leech species used in medicinal leech therapy (MLT) that has antithrombotic and anti-inflammatory properties. When applied to affected areas, these leeches secrete bioactive substances including hirudin (a potent anticoagulant), anti-inflammatory compounds, and vasodilators. Qurs Mafasil is a Unani herbal tablet formulation used for joint conditions, particularly gout and rheumatism, that helps reduce uric acid levels and inflammation. The combination may provide complementary benefits for inflammatory joint conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hirudinaria granulosa + qurse mafasil.